Original Article

Journal of Cerebral Blood Flow & Metabolism (2007) 27, 1965–1974; doi:10.1038/sj.jcbfm.9600488; published online 4 April 2007

Evaluation of reference regions for (R)-[11C]PK11195 studies in Alzheimer's disease and Mild Cognitive Impairment

Additional support was provided by research grants from the European Union (NCI-MCI project, number QLK6-CT-2000-00502), the Netherlands Organisation for Scientific Research (NOW VIDI grant 016.066.309), and from the Dutch Brain Foundation (number 9F01.21).

Marc A Kropholler1, Ronald Boellaard1, Bart N M van Berckel1, Alie Schuitemaker2, Reina W Kloet1, Mark J Lubberink1, Cees Jonker3, Philip Scheltens4 and Adriaan A Lammertsma1

  1. 1Department of Nuclear Medicine & PET Research, VU University Medical Centre, Amsterdam, The Netherlands
  2. 2Department of Nuclear Medicine & PET Research, Department of Neurology & Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
  3. 3Institute for Research in Extramural Medicine, VU University Medical Centre, Amsterdam, The Netherlands
  4. 4Department of Neurology & Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands

Correspondence: Dr R Boellaard, Department of Nuclear Medicine & PET Research, VU University Medical Centre, MB Amsterdam 1007, The Netherlands. E-mail: r.boellaard@vumc.nl

Received 19 October 2006; Revised 8 February 2007; Accepted 13 February 2007; Published online 4 April 2007.

Top

Abstract

Inflammation in Alzheimer's disease (AD) may be assessed using (R)-[11C]PK11195 and positron emission tomography. Data can be analyzed using the simplified reference tissue model, provided a suitable reference region is available. This study evaluates various reference regions for analyzing (R)-[11C]PK11195 scans in patients with mild cognitive impairment (MCI) and probable AD. Healthy subjects (n=10, 30plusminus10 years and n=10, 70plusminus6 years) and patients with MCI (n=10, 74plusminus6 years) and probable AD (n=9, 71plusminus6 years) were included. Subjects underwent a dynamic three-dimensional (R)-[11C]PK11195 scan including arterial sampling. Gray matter, white matter, total cerebellum and cerebrum, and cluster analysis were evaluated as reference regions. Both plasma input binding potentials of these reference regions (BPPLASMA) and corresponding reference region input binding potentials of a target region (BPSRTM) were evaluated. Simulations were performed to assess cluster analysis performance at 5% to 15% coefficient of variation noise levels. Reasonable correlations for BPPLASMA (R2=0.52 to 0.94) and BPSRTM (R2=0.59 to 0.76) were observed between results using anatomic regions and cluster analysis. For cerebellum white matter, cerebrum white matter, and total cerebrum a considerable number of unrealistic BPSRTM values were observed. Cluster analysis did not extract a valid reference region in 10% of the scans. Simulations showed that potentially cluster analysis suffers from negative bias in BPPLASMA. Most anatomic regions outperformed cluster analysis in terms of absence of both scan rejection and bias. Total cerebellum is the optimal reference region in this patient category.

Keywords:

Alzheimer's disease, cluster analysis, PK11195, reference region, reference tissue, tracer kinetic modelling

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT